Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
51.91 USD | +2.81% | +5.04% | +45.90% |
10/05 | Crinetics Pharmaceuticals Insider Sold Shares Worth $5,307,931, According to a Recent SEC Filing | MT |
09/05 | Crinetics Pharmaceuticals Q1 Net Loss Widens | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+45.90% | 409.36Cr | |
+33.37% | 5.08TCr | |
+1.55% | 4.28TCr | |
+49.11% | 4.2TCr | |
-4.22% | 2.95TCr | |
+11.57% | 2.61TCr | |
-21.00% | 1.91TCr | |
+7.36% | 1.31TCr | |
+28.30% | 1.22TCr | |
+23.80% | 1.21TCr |
- Stock Market
- Equities
- CRNX Stock
- News Crinetics Pharmaceuticals, Inc.
- Transcript : Crinetics Pharmaceuticals, Inc. Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-11-2023 03